- Home
- GILD vs PGR Comparison
GILD vs PGR Comparison
Compare GILD & PGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PGR
- Stock Information
- Founded
- GILD 1987
- PGR 1937
- Country
- GILD United States
- PGR United States
- Employees
- GILD N/A
- PGR N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PGR Property-Casualty Insurers
- Sector
- GILD Health Care
- PGR Finance
- Exchange
- GILD Nasdaq
- PGR Nasdaq
- Market Cap
- GILD 140.8B
- PGR 141.3B
- IPO Year
- GILD 1992
- PGR N/A
- Fundamental
- Price
- GILD $119.02
- PGR $250.95
- Analyst Decision
- GILD Buy
- PGR Buy
- Analyst Count
- GILD 24
- PGR 15
- Target Price
- GILD $114.26
- PGR $287.20
- AVG Volume (30 Days)
- GILD 6.4M
- PGR 3.1M
- Earning Date
- GILD 08-07-2025
- PGR 07-16-2025
- Dividend Yield
- GILD 2.65%
- PGR 1.95%
- EPS Growth
- GILD 496.80
- PGR 52.01
- EPS
- GILD 5.01
- PGR 17.75
- Revenue
- GILD $28,863,000,000.00
- PGR $82,376,000,000.00
- Revenue This Year
- GILD $1.91
- PGR $14.11
- Revenue Next Year
- GILD $3.75
- PGR $10.57
- P/E Ratio
- GILD $23.75
- PGR $14.14
- Revenue Growth
- GILD 3.81
- PGR 21.50
- 52 Week Low
- GILD $72.89
- PGR $226.52
- 52 Week High
- GILD $121.83
- PGR $292.99
- Technical
- Relative Strength Index (RSI)
- GILD 60.91
- PGR 54.21
- Support Level
- GILD $108.54
- PGR $241.55
- Resistance Level
- GILD $121.83
- PGR $249.20
- Average True Range (ATR)
- GILD 2.53
- PGR 4.18
- MACD
- GILD 0.67
- PGR 1.50
- Stochastic Oscillator
- GILD 78.86
- PGR 86.42
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About PGR Progressive Corporation (The)
Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 24 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.